Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm
Retrieved on:
Tuesday, July 26, 2022
Health, Medical Devices, Technology, Health Technology, Software, Radiology, Artificial Intelligence, MRI, Algorithm, Diagnosis, Time, Mortality, Neuroimaging, Physician, U.S. Securities and Exchange Commission, Decision-making, Doctor of Philosophy, Health, Hospital, Partnership, Associate, Private Securities Litigation Reform Act, Marketing, University Medical Center, Deep learning, Income, US, Disease, COVID-19, US FDA, EMEA, Multimedia, Neuro, Machine learning, Mission statement, Magnetic resonance imaging, Technology, Â, FDA, Ohio State University Wexner Medical Center, Patient, Transport, ER, Nasdaq, Security (finance), Stroke, Humanitarian use licenses, Forbes, Growth, Swoop, AI, ICU, Surgery, Medical imaging, MD, Hyperfine structure
Together, they will bring MRI to the patients bedside and deliver valuable insights to the clinicians fingertips for timely decision making.
Key Points:
- Together, they will bring MRI to the patients bedside and deliver valuable insights to the clinicians fingertips for timely decision making.
- Swoop, the worlds first MR imaging system capable of providing neuroimaging at the point of care, expands patient access to MRI by bringing imaging to the bedside.
- With this partnership, we will be able to combine Vizs intelligent care coordination platform and leading image viewer with the Hyperfine Swoop Portable MR Imaging System.
- Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first US FDA-cleared portable MRI system.